Medical School or Training

Residency

Board Certification

Radiation Oncology

Research

Breast-conserving therapy in breast cancer, the effect of radiation therapy in patients with BRCA-1 or BRCA-2, and post mastectomy radiotherapy.

Biography

Dr. Lori Pierce attended Duke University School of Medicine and completed a radiation oncology residency and chief residency at the University of Pennsylvania Hospital. She then became a senior investigator at the National Cancer Institute, National Institutes of Health in Bethesda, Md. In 1992, Dr. Pierce joined the faculty of the University of Michigan. Since coming to Michigan, she has served as residency director and clinical director in the Department of Radiation Oncology. In August 2005, Dr. Pierce was appointed by the University of Michigan Board of Regents to be Associate Provost for Academic and Faculty Affairs. Her research focuses on the use of radiotherapy in the multi-modality treatment of breast cancer, with emphasis on intensity modulated radiotherapy in node positive breast cancer and the use of radiation in women with breast cancer who also have a BRCA1/2 breast cancer susceptibility gene.